September 23, 2022 04:36 AM
By Davit Kirakosyan
Each day Wall Street research analysts initiate new coverage on stocks in the sectors they follow and establish ratings, like Buy/Hold/Sell, set price targets, and publish earnings and other financial estimates. Below are 5 new coverage stocks that grabbed our attention today:
RBC Capital initiated coverage on Nike (NYSE:) with an Outperform rating and a price target of $125.00, viewing China recovery as the catalyst to improve sentiment, which shows early signs of promise. According to the brokerage, the company has proven its ability to remain one step ahead, with Digital business transformation, China app relaunch, ERP upgrade and RTFKT acquisition recent proof points.
Goldman Sachs initiated coverage on Revance Therapeutic (NASDAQ:) with a Buy rating and a price target of $33.00.
Baird initiated coverage on Netstreit Corp (NYSE:) with an Outperform rating and a price target of $23.00, noting it believes the combination of a high-quality in-place portfolio, steady acquisition activity and reasonable valuation should drive outperformance.
Raymond James initiated coverage on Prudential Financial (NYSE:) with a Strong Buy rating and a price target of $115.00.
Cowen initiated coverage on 23AndMe Holding Co (NASDAQ:) with an Outperform rating and a price target of $6.00 given the differentiated assets and significant cash runway.